Articles

Pages

A consortium led by retinal gene therapy company Gyroscope Therapeutics Ltd. (Stevenage, U.K.) received a two-year, £1.1 million ($1.4 million) award from Innovate UK to develop a manufacturing platform for production of adeno-associated virus (AAV)...

The DeepMind Technologies subsidiary of Alphabet Inc. (NASDAQ:GOOG) is merging its health team into Google Inc. following Google's announcement that David Feinberg will be joining the tech company to organize its healthcare efforts. Feinberg is...

Beyond a quick mention of Verily Life Sciences LLC and AI, Google Inc. is saying little about what it plans to do with its healthcare initiatives now that David Feinberg is leaving Geisinger Health System...

uniQure N.V. (NASDAQ:QURE) reported that all three patients who received hemophilia B gene therapy AMT-061 in a dose-confirmation Phase IIb trial achieved and sustained therapeutic levels of Factor IX activity. The company has started enrollment...

Oxford BioDynamics plc (LSE:OBD) said it partnered with an undisclosed major U.S. pharma to use its EpiSwitch epigenetic biomarker platform to develop predictive biomarkers for immuno-oncology therapeutics. The company did not respond to inquiries.
Oxford BioDynamics...